TNGX icon

Tango Therapeutics
TNGX

Overview Fund Activity

137 hedge funds and large institutions have $329M invested in Tango Therapeutics in 2024 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 27 closing their positions.

Holders
137
Holders Change
+16
Holders Change %
+13.22%
% of All Funds
1.82%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
44
Increased
40
Reduced
28
Closed
27
Calls
$4K
Puts
$14K
Net Calls
-$10K
Net Calls Change
-$17K

Top Buyers

1
TCM
1
TCG Crossover Management
California
$33.2M
2
BCM
2
Boxer Capital Management
California
$32.1M
3
GS
3
Gilead Sciences
California
$15M
4
FCM
4
Farallon Capital Management
California
$12.4M
5
NCM
5
Nantahala Capital Management
Connecticut
$8.67M

Top Sellers

1
BC
1
Boxer Capital
California
$0
2
SCA
2
Southpoint Capital Advisors
New York
$0
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$27.3K
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$0
5
DM
5
Deerfield Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TGI
1
TRV GP IV
Massachusetts
$52.1M 16,859,075 – –
TCM
2
TCG Crossover Management
California
$33.2M 10,736,000 +10,736,000 New
EC
3
EcoR1 Capital
California
$32.8M 10,630,736 -2,700,000 -20%
BCM
4
Boxer Capital Management
California
$32.1M 10,380,999 +10,380,999 New
NI
5
Nextech Invest
Switzerland
$17.1M 5,533,980 – –
GS
6
Gilead Sciences
California
$15M 4,854,443 +4,854,443 New
BlackRock
7
BlackRock
New York
$13.5M 4,378,503 +17,168 +0.4%
FCM
8
Farallon Capital Management
California
$12.4M 4,000,000 +4,000,000 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$12.3M 3,985,225 +339,922 +9%
T. Rowe Price Investment Management
10
T. Rowe Price Investment Management
Maryland
$10.3M 3,345,551 -1,677,595 -33%
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$10.1M 3,279,196 +592,000 +22%
NCM
12
Nantahala Capital Management
Connecticut
$8.67M 2,804,410 +2,804,410 New
BCLSI
13
Bain Capital Life Sciences Investors
Massachusetts
$8.38M 2,712,008 – –
SL
14
Siren LLC
Connecticut
$8.05M 2,603,897 – –
BOCH
15
Blue Owl Capital Holdings
New York
$5.35M 1,732,152 +1,732,152 New
Citadel Advisors
16
Citadel Advisors
Florida
$5.03M 1,626,759 -1,067,366 -40%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.29M 1,386,449 +18,187 +1%
State Street
18
State Street
Massachusetts
$3.8M 1,231,199 -1,087,009 -47%
CC
19
Casdin Capital
New York
$3.67M 1,188,349 – –
Bessemer Group
20
Bessemer Group
New Jersey
$2.19M 708,384 – –
ACH
21
ArrowMark Colorado Holdings
Colorado
$2.19M 708,385 – –
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$2.05M 662,776 +302,087 +84%
Schroder Investment Management Group
23
Schroder Investment Management Group
United Kingdom
$2.03M 655,158 +655,158 New
SB
24
Samsara BioCapital
California
$1.95M 630,000 – –
O
25
OrbiMed
New York
$1.7M 550,000 +550,000 New
1
2 3 4 5